Search

Search bills, members, committees and pages...

Sign In

ACADIA PHARMACEUTICALS

PreviousNext

19 federal lobbying filings, 2023 to 2026.

ACADIA PHARMACEUTICALS is a client on 19 federal lobbying filings, 2023 to 2026, reporting $100K across them. Biopharmaceutical company. Based in California.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 it has hired, by filings.

RegistrantFilingsReported
ACADIA PHARMACEUTICALS14—
LMH STRATEGIC SOLUTIONS5$100K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262—$1.3M
20259$100K$2.3M
20244—$1.4M
20234—$1M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
MMMMedicare/Medicaid19
HCRHealth Issues14
TAXTaxation/Internal Revenue Code7
PHAPharmacy5
TRDTrade (domestic/foreign)3

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1262Mikaela Naylon Give Kids a Chance Act6
H.R. 1414Cameron’s Law6
H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…6
H.R. 946ORPHAN Cures Act6
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.5
H.R. 1509Accelerating Kids’ Access to Care Act of 20255
H.R. 3731Small Biotech Innovation Act5
H.R. 6130ASAP Act2
S. 3267ASAP Act2
H.R. 9102BINSA Act1

Lobbyists

Named on the filings.

LobbyistClientsFilings
MICHAEL MATTOON114
ALANNA TEMME15
SARAH TELLOCK15

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2026 second_quarter$700KJul 20, 2026
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2026 first_quarter$600KApr 20, 2026
ACADIA PHARMACEUTICALSLMH STRATEGIC SOLUTIONS2025 fourth_quarter$30KApr 16, 2026
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2025 fourth_quarter$590KJan 19, 2026
ACADIA PHARMACEUTICALSLMH STRATEGIC SOLUTIONS2025 fourth_quarter$30KJan 12, 2026
ACADIA PHARMACEUTICALSLMH STRATEGIC SOLUTIONS2025 third_quarter$30KOct 20, 2025
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2025 third_quarter$750KOct 19, 2025
ACADIA PHARMACEUTICALSLMH STRATEGIC SOLUTIONS2025 second_quarter$10KJul 21, 2025
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2025 second_quarter$500KJul 21, 2025
ACADIA PHARMACEUTICALSLMH STRATEGIC SOLUTIONS2025 second_quarter—Jul 16, 2025
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2025 first_quarter$440KApr 18, 2025
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2024 fourth_quarter$510KJan 20, 2025
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2024 third_quarter$220KOct 21, 2024
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2024 second_quarter$450KJul 22, 2024
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2024 first_quarter$250KApr 16, 2024
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2023 fourth_quarter$240KJan 19, 2024
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2023 third_quarter$180KOct 18, 2023
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2023 second_quarter$230KJul 20, 2023
ACADIA PHARMACEUTICALSACADIA PHARMACEUTICALS2023 first_quarter$390KApr 19, 2023